Our study demonstrates that hs-cTnI has the greatest impact when predicting the risk of MACE, CV mortality, and all-cause mortality in patients with HD, surpassing established risk markers such as BNP, age, previous CV events, hypertension, dyslipidaemia, diabetes mellitus, and smoking. Here, NPPB is linked to inherited lipid metabolism disorder.